Altamira Therapeutics Announces Collaboration on Circular RNA Delivery
Globenewswire· 2025-05-27 13:00
Hamilton, May 27, 2025 (GLOBE NEWSWIRE) -- Exploring use of Altamira’s RNA nanoparticles in conjunction with circular RNA payloads Project collaboration partner will have option to negotiate licensing agreement Altamira Therapeutics Ltd. (“Altamira” or the “Company”) (OTCQB:CYTOF), a company dedicated to developing and commercializing RNA delivery technology for targets beyond the liver, today announced that it has entered into a collaboration agreement with an undisclosed company to evaluate the potential ...
Kura Sushi USA to Participate in Two Investor Conferences in June
Globenewswire· 2025-05-27 13:00
IRVINE, Calif., May 27, 2025 (GLOBE NEWSWIRE) -- Kura Sushi USA, Inc. (“Kura Sushi” or the “Company”), (NASDAQ: KRUS), a technology-enabled Japanese restaurant concept, today announced that it will participate in two upcoming investor conferences: On Tuesday, June 3, 2025, the Company will host a fireside chat at William Blair’s 45th Annual Growth Stock Conference in Chicago, IL. Kura’s discussion will begin at 12:00 p.m. CT and will be webcast live on our corporate website at www.kurasushi.com under the in ...
NurExone Biologic Inc. Announces First Quarter 2025 Financial Results and Provides Corporate Update
Globenewswire· 2025-05-27 12:59
TORONTO and HAIFA, Israel, May 27, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“ NurExone ” or the “ Company ”), a preclinical-stage biotechnology company pioneering exosome-based therapies for central nervous system injuries, is pleased to announce its financial results for the first quarter ended March 31, 2025, and provides a corporate update on its recent activities and upcoming milestones. The Company’s full set of unaudited condensed interim consolidated fina ...
LPL Financial Welcomes Beamish Wealth Management to Linsco Channel
Globenewswire· 2025-05-27 12:55
SAN DIEGO, May 27, 2025 (GLOBE NEWSWIRE) -- LPL Financial LLC announced today that financial advisor Colin Beamish, CFP®, has joined LPL’s employee advisor channel, Linsco by LPL Financial, to launch Beamish Wealth Management of LPL Financial. He reported serving approximately $445 million in advisory, brokerage and retirement plan assets* and joins LPL from City National Securities, Inc., a subsidiary of RBC. Based in San Diego, Beamish transitioned to financial services in 2006 from the sports industry ...
Lottery.com and Sports.com Driver Receives Top Rookie Honors at the Indy 500
Globenewswire· 2025-05-27 12:53
INDIANAPOLIS, May 27, 2025 (GLOBE NEWSWIRE) -- In the running of the 109th Indianapolis 500, Louis Foster delivered a headline-grabbing performance as Top Rookie finisher, proudly representing Sports.com and Lottery.com Inc. (Nasdaq: LTRY; LTRYW) (“Lottery.com” or “the Company”) in what marked a milestone weekend for the brands' growing presence in global motorsport. Callum Ilott (red) and Louis Foster (black) stand next to the Borg-Warner Trophy prior to the start of the 2025 Indy 500. Driving the #45 De ...
TRESU Investment Holding A/S – Announcement of Q1 2025 Interim Report
Globenewswire· 2025-05-27 12:50
TRESU INVESTMENT HOLDING A/S ANNOUNCEMENT NO. 07.2025 27.05.2025 TRESU Investment Holding A/S – Announcement of Q1 2025 Interim Report Tresu Investment Holding A/S today publishes the Q1 2025 Interim Report and presentation of the financial results. We are pleased to invite you to the financial results call, which is being held Wednesday, 11. June 2025, at 1pm CET. The Interim Report will be presented by Stephan Plenz, CEO and Torben Børsting, CFO. After the presentations there will be an opportunity for Q ...
Leo International leaps from Lion City to Frankfurt with AI precision health listing
Globenewswire· 2025-05-27 12:45
SINGAPORE, May 27, 2025 (GLOBE NEWSWIRE) -- In a landmark announcement that bridges Asia and Europe, Leo International Group has acquired a controlling stake in SPOABG AG, a publicly listed company on the Frankfurt Stock Exchange (FSE). The company has now been officially renamed Leo International Precision Health AG (LIPH AG), with updated ticker symbols “LEOW.F” and “LEOW.DU”. This momentous move marks the first time in a century that a Taiwanese-founded enterprise has achieved mainboard listing status o ...
TruGolf Clarifies Nasdaq Compliance Plan and Provides Context to Equity Line of Credit
Globenewswire· 2025-05-27 12:45
Salt Lake City, Utah, May 27, 2025 (GLOBE NEWSWIRE) -- TruGolf Holdings, Inc. (NASDAQ: TRUG), a leading golf technology company, has clarified its plan to regain compliance with Nasdaq listing rules in response to shareholder inquiries. On August 19, 2024, TruGolf Holdings, Inc. received a written notification from the Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market (“Nasdaq”) notifying the Company that, the Company’s stockholders’ equity was ($10,508,104), and therefore, the Comp ...
Ormat Technologies Announces $62 Million Hybrid Tax Equity Partnership for Two Energy Storage Facilities
Globenewswire· 2025-05-27 12:45
RENO, Nev., May 27, 2025 (GLOBE NEWSWIRE) -- Ormat Technologies, Inc. (NYSE: ORA) (the “Company” or “Ormat”), a leading geothermal and renewable energy company, today announced the signing of a $62 million Hybrid Tax Equity partnership with Morgan Stanley Renewables, Inc. The partnership’s transaction covers the Lower Rio 60MW/120MWh storage facility and the Arrowleaf 35MW/140MWh storage and 42MW solar projects, which are expected to achieve COD by the end of 2025. “This Hybrid Tax Equity partnership is the ...
Vaccinex to Report Promising New Clinical Results of Neoadjuvant Treatment with Pepinemab to Enhance Immunotherapy in Patients with Head and Neck Cancer at ASCO Annual Meeting
Globenewswire· 2025-05-27 12:45
Neoadjuvant treatment with pepinemab appears to induce abundant, mature lymphoid structures that correlate with improved pathologic response.ROCHESTER, N.Y., May 27, 2025 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage biotechnology company pioneering a differentiated approach to treating cancer and Alzheimer’s disease (AD) through the inhibition of Semaphorin 4D (SEMA4D), today announced that it will present new data characterizing the unique mechanism of pepinemab to enhance immune res ...